SALT LAKE CITY, March 16, 2011 (GLOBE NEWSWIRE) -- Myrexis, Inc. (Nasdaq:MYRX), a biotechnology company focused on discovering, developing, and commercializing novel treatments for cancer, today announced that Adrian Hobden, Ph.D., President and Chief Executive Officer, is scheduled to present an overview of the Company at the 10th Annual Needham Healthcare Conference to be held April 5 – 6, 2011 in New York City.
